Sugi Predict

Sugi Predict / Compounds / SCHEMBL253482

SCHEMBL253482

SCHEMBL253482

C=CC[Si](CC=C)(COC(=O)c1ccccc1)COC(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.49
▸ MAPK1 P28482 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ LMNA P02545 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ F2 P00734 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ HPGD P15428 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2687243 0.77 LMNA (0.59) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL17520050 0.77 LMNA (0.59) TDP1MAPK1HIF1ASLC6A2SLC6A3
Benzene SCHEMBL28207781 0.77 CYP3A4 (0.69) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL21007 0.77 CYP3A4 (0.69) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL28343462 0.77 CYP3A4 (0.69) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL10908798 0.76 AKT1 (0.47) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL1355708 0.75 CYP3A4 (0.67) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL11306827 0.75 CYP3A4 (0.67) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL2788103 0.75 CYP3A4 (0.67) TDP1MAPK1HIF1ASLC6A2SLC6A3
SCHEMBL7587574 0.75 CYP3A4 (0.67) TDP1MAPK1HIF1ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350144-B1 PROCATALYST COMPOSITION INCLUDING SILYL ESTER INTERNAL DONOR AND METHOD GRACE W R & CO (US) 2015-07-15 — — EP disclosed
US-8088872-B2 Procatalyst composition including silyl ester internal donor and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-01-03 — — US disclosed
EP-2350144-A1 PROCATALYST COMPOSITION INCLUDING SILYL ESTER INTERNAL DONOR AND METHOD Dow Global Technologies LLC (US) 2011-08-03 — — EP disclosed
WO-2010065361-A1 PROCATALYST COMPOSITION INCLUDING SILYL ESTER INTERNAL DONOR AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-06-10 — — WO disclosed
US-20100130709-A1 Procatalyst Composition Including Silyl Ester Internal Donor and Method W. R. GRACE & CO.-CONN. 2010-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130709-A1 Procatalyst Composition Including Silyl Ester Internal Donor and Method GNE, NANS, ELANE TDP1 2949/4885MAPK1 2989/4885HIF1A 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.